share_log
Benzinga ·  Nov 11 08:20
CERo Therapeutics Presents Preclinical Data At SITC 2024 Showing CER-1236 Effectively Kills Ovarian Cancer Cells Without Toxicity In Animal Models
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment